Switching from Escitalopram to Sertraline: A Guideline Summary
Introduction to Switching Strategy
- The American Academy of Family Physicians recommends starting sertraline at 25-50 mg/day while beginning to taper escitalopram 1
- The American Academy of Family Physicians suggests reducing escitalopram by 50% (e.g., from 10 mg to 5 mg) for 3-7 days while maintaining the initial sertraline dose 2
- The American Academy of Pediatrics recommends increasing sertraline to target dose (50-200 mg/day) over the following week as tolerated 1
Monitoring and Tolerability
- The American Academy of Family Physicians advises monitoring closely for adverse events from sertraline initiation, such as gastrointestinal symptoms, insomnia, nervousness, and tremors 2
- The American Academy of Pediatrics recommends contact within the first week to assess tolerability and adherence 1
- The American Academy of Family Physicians suggests assessing response to sertraline at 4-6 weeks after reaching therapeutic dose 1
Critical Safety Considerations
- The American Academy of Pediatrics warns to never combine SSRIs with MAOIs, as both escitalopram and sertraline are contraindicated with monoamine oxidase inhibitors 1
- The American Academy of Pediatrics advises not to start sertraline at high doses, as higher starting doses increase risk of behavioral activation and suicide-related events 1
- The American Academy of Family Physicians notes that sertraline has less effect on metabolism of other medications compared to other SSRIs, making it a favorable choice when drug interactions are a concern 2
Expected Outcomes
- The Annals of Internal Medicine reports that no significant efficacy differences exist between escitalopram and sertraline, with both being effective first-line treatments for major depressive disorder 3
- The Annals of Internal Medicine states that switching between SSRIs shows similar outcomes to continuing the same medication when done appropriately 3
- The American Academy of Family Physicians notes that sertraline may have slightly better tolerability in some patients due to fewer drug interactions 2